San Francisco, CANCT06616025Now EnrollingIRB Ready

Nerve Injury Clinical Trial in San Francisco, CA

Access cutting-edge nerve injury treatment through this phase 3 clinical trial at a research site in San Francisco. Study-provided care at no cost to qualified participants.

Sponsored by Neuraptive Therapeutics Inc.

Quick Self-Assessment

See if you qualify for this San Francisco location

Preparing your pre-screening questions…

Expert Care in San Francisco

Access nerve injury specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related nerve injury treatment provided free

Apply for This San Francisco Location

Check if you qualify for this nerve injury clinical trial in San Francisco, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to San Francisco

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit San Francisco site if eligible
  4. 4Begin participation

About This Nerve Injury Study in San Francisco

NTX-001 is a single use surgical product intended for use in conjunction with standard suture neurorrhaphy of severed nerves in patients between 18 and 80.

Sponsor: Neuraptive Therapeutics Inc.

Who Can Participate

Inclusion Criteria

The subject has voluntarily agreed to participate in this study and has signed an Institutional Review Board (IRB) approved informed consent form.
The subject is between eighteen (18) and eighty (80) years of age.
The subject has clinical evidence of a Sunderland's 4th degree (Class II) or 5th degree (Class III) nerve transection(s) that has resulted in upper extremity nerve impairment that requires surgical treatment.

Exclusion Criteria

Subjects whose nerve repair will occur greater than 48 hours after nerve transection.
Subjects requiring nerve repair involving an autograft, allograft or conduit(s).
Subjects with multiple transected nerve injuries are allowed into the study only if all injuries are amenable to direct repair.
Subjects who, in the judgement of the investigator, are not likely to demonstrate meaningful recovery within a reasonable time frame during follow up due to significant muscle atrophy or other morbidity.
The subject's injury is a result of a suicide attempt or self- harm.
The subject has documented history or clinical signs of any condition where NTX-001 might not prove beneficial (e.g., systemic neuromuscular disease, systemic neurological deficit, or other treatments known to affect the growth and/or physiology of the neural and vascular system).
The subject has a known allergy to polyethylene glycol (PEG) or human grade silicone.
The subject is pregnant or breastfeeding.
The subject is currently enrolled in another investigational study or has participated in an investigational study within 30 days prior to screening.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in San Francisco?

Yes, this clinical trial (NCT06616025) has an active research site in San Francisco, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Nerve Injury Treatment Options in San Francisco, CA

If you're searching for nerve injury treatment options in San Francisco, CA, this clinical trial (NCT06616025) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our San Francisco research site is actively enrolling participants for this phase 3 clinical trial. You'll receive care from experienced nerve injury specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Ready to Join in San Francisco?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · San Francisco, CA